Congenital ranula: a case report

The purpose of this study was to report a case of bilateral swelling on the floor of the mouth of a 7-month-old patient. The lesion was congenital and had started to cause feeding problems. After the clinical diagnosis of ranula was made, the lesion was marsupialized. The obtained specimen was submitted for histopathological examination, which revealed an epithelial-lined cystic lesion. These results led to the final diagnosis of mucus retention cyst. After an 8-year follow-up period, the patient is in good general health with no recurrences.

Fibroma ossificante periférico: relato de caso

The Peripheral ossifying fibroma is a reactive proliferative lesion, non neoplastic, slow growth, which can produce recurrence after removal. It´s etiology is uncertain, but is associated with local irritants, and is found mostly in the anterior maxilla. Clinically it is characterized by an asymptomatic increase in volume, which may, over time, facial asymmetry. The aim of this paper is to describe a case of peripheral ossifying fibroma in a patient 40, female, exophytic lesion in the jaw, unusual for its large dimensions and with a history of three recurrences, leading to facial asymmetry. She underwent surgery to remove the lesion along with the likely irritants, and the pathological diagnosis of peripheral ossifying fibroma. We conclude that it is fundamentally important for complete removal of the lesion to reduce the tendency to relapse, including the periosteum and the periodontal ligament, in addition to possible causes.

Tumor odontogênico de células granulares

Introduction: the granular cell odontogenic tumors are an uncommon neoplasm with benign clinical behavior. The lesion occurs over a wide age range with a typically predilection for the mandibular canine and molar regions. Aim: present a granular cell odontogenic tumor literature review. Conclusions: the tumor don’t present an aggressive biological behavior although recurrences can occur. The lesion is treated by conservative surgery with curettage and enucleation as election procedures.

Biological therapy for the prevention and treatment of postoperative endoscopic recurrence in Crohn's disease: time for acceptance?

In most patients, postoperative endoscopic recurrence (PER) occurs 1 year after abdominal resection for Crohn’s disease (CD). Preventing PER is essential for disease control, as most patients develop further clinical and surgical recurrences. Conventional therapy with nitroimidazoles, aminosalicylates, and immunomodulators have limited efficacy for preventing PER. Initial trials with biological therapy (infliximab and adalimumab) showed promising results in preventing PER, and the efficacy of these drugs seems higher than that with conventional therapy. The aim of this review is to outline the results of studies that used infliximab or adalimumab for preventing and treating PER in CD patients. Data with both agents are available, and a few, small prospective trials have shown the efficacy of these drugs in patients with a high risk for recurrence. We believe that, in 2013, biological agents will be better accepted for the prevention PER in CD patients, in addition to the already existing data. Larger trials are still underway, and their results will certainly determine the role of these agents in PER, which develops after bowel resection for CD.

Equações de diferenças: aplicações no ensino médio

Pós-graduação em Matemática em Rede Nacional - IBILCE